Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive IPAH and COVID-19 Infection

(2020) Roham T Zamanian et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome

(2020) Luciano Gattinoni et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view

(2020) Andreas Kronbichler et al.   AUTOIMMUNITY REVIEWS

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis

(2020) Zhikang Ye et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

ACE Inhibitors and ARBs in Patients with COVID-19

(2020) Grace I. Shyh et al.   Cardiology in Review

Differentiating COVID-19 Pneumonia from Acute Respiratory Distress Syndrome (ARDS) and High Altitude Pulmonary Edema (HAPE): Therapeutic Implications

(2020) Stephen L. Archer et al.   CIRCULATION

COVID-19 and pulmonary hypertension

(2020) Samar Farha   CLEVELAND CLINIC JOURNAL OF MEDICINE

Pulmonary embolism in patients with Covid-19 pneumonia

(2020) Florian Bompard et al.   EUROPEAN RESPIRATORY JOURNAL

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

The epidemiology, diagnosis and treatment of COVID-19

(2020) Pan Zhai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19

(2020) Ping Li et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Management of COVID-19 Respiratory Distress

(2020) John J. Marini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ramipril in High Risk Patients with COVID-19

(2020) Ignacio J. Amat-Santos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19

(2020) Ishan Paranjpe et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients

(2020) Sebastian Voicu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

(2020) Elissa Driggin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thromboinflammation and the hypercoagulability of COVID‐19

(2020) Jean M. Connors et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

(2020) Jecko Thachil et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

COVID-19 update: Covid-19-associated coagulopathy

(2020) Richard C. Becker   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effective treatment of severe COVID-19 patients with tocilizumab

(2020) Xiaoling Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

(2020) Peter M George et al.   Lancet Respiratory Medicine

Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective

(2020) Thea Magrone et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Bo Diao et al.   Frontiers in Immunology

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Tao Guo et al.   JAMA Cardiology

Progress and Prospects on Vaccine Development against SARS-CoV-2

(2020) Jinyong Zhang et al.   Vaccines

Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives

(2020) Carla Felice et al.   AMERICAN JOURNAL OF HYPERTENSION

Novel insights on the pulmonary vascular consequences of COVID-19

(2020) François Potus et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Unexpected favourable course of Coronavirus Disease 2019 in chronic thromboembolic pulmonary hypertension patients

(2020) Teresa Segura de la Cal et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019

(2020) Yong-Jian Geng et al.   CARDIOVASCULAR PATHOLOGY

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

(2020) Alice Huertas et al.   EUROPEAN RESPIRATORY JOURNAL

Renin-Angiotensin System Blockers and the COVID-19 Pandemic

(2020) A.H. Jan Danser et al.   HYPERTENSION

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Why not consider an endothelin receptor antagonist against SARS‐CoV‐2?

(2020) S. Javor et al.   MEDICAL HYPOTHESES

Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar

(2020) Jorge Nuche et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project

(2020) Andrea M. Isidori et al.   Andrology

Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19

(2020) Teluguakula Narasaraju et al.   Frontiers in Pharmacology

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19

(2020) Bhawna Tomar et al.   Cells

Neutrophil extracellular traps in COVID-19

(2020) Yu Zuo et al.   JCI Insight

Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?

(2020) L.F. van Dam et al.   THROMBOSIS RESEARCH

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

(2019) Paul La Rosée et al.   BLOOD

RhoA-Rho associated kinase signaling leads to renin-angiotensin system imbalance and angiotensin converting enzyme 2 has a protective role in acute pulmonary embolism

(2019) Xiaoling Xu et al.   THROMBOSIS RESEARCH

The stimulation of thrombosis by hypoxia

(2019) Neha Gupta et al.   THROMBOSIS RESEARCH

Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014

(2019) Eileen M. Harder et al.   RESPIRATORY MEDICINE

AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension

(2018) Jiao Zhang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in PAH with HIF-2α Inhibitor

(2018) Zhiyu Dai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

(2018) Anna R. Hemnes et al.   EUROPEAN RESPIRATORY JOURNAL

Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension

(2018) Soni Savai Pullamsetti et al.   JOURNAL OF CLINICAL INVESTIGATION

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

(2018) Marc Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

(2018) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Chronic thromboembolic pulmonary hypertension

(2018) Nick H. Kim et al.   EUROPEAN RESPIRATORY JOURNAL

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

(2017) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

More than an anticoagulant: Do heparins have direct anti-inflammatory effects?

(2017) Timothy J. Poterucha et al.   THROMBOSIS AND HAEMOSTASIS

Coagulation and sepsis

(2017) Marcel Levi et al.   THROMBOSIS RESEARCH

Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis

(2016) Raquel Rios-Fernández et al.   AMERICAN JOURNAL OF THERAPEUTICS

New Molecular Targets of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

(2015) Christophe Guignabert et al.   CHEST

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response

(2015) Yue-Hui Zhang et al.   INFLAMMATION RESEARCH

The role of inhaled prostacyclin in treating acute respiratory distress syndrome

(2015) Randi J. Searcy et al.   Therapeutic Advances in Respiratory Disease

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

(2014) M. Furuhashi et al.   AMERICAN JOURNAL OF HYPERTENSION

Bosentan as Rescue Treatment in Refractory Hypoxemia and Pulmonary Hypertension in a Patient with ARDS and H7N9 Influenza Virus Infection

(2014) Qiang Guo et al.   LUNG

Endothelin-1 Downregulates Angiotensin-Converting Enzyme-2 Expression in Human Bronchial Epithelial Cells

(2013) Hongliang Zhang et al.   PHARMACOLOGY

Modern Age Pathology of Pulmonary Arterial Hypertension

(2012) Elvira Stacher et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases

(2012) Rodrigo Fraga-Silva et al.   THROMBOSIS AND HAEMOSTASIS

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

(2010) Lorinda Chung et al.   CHEST

Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS

(2010) Alexander D. Cornet et al.   INTENSIVE CARE MEDICINE

Unknown

(2010) Rodrigo Fraga-Silva et al.   MOLECULAR MEDICINE

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension

(2009) B. Sztrymf et al.   EUROPEAN RESPIRATORY JOURNAL

Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade

(2008) Michiya IGASE et al.   HYPERTENSION RESEARCH